Impact of short-term esomeprazole treatment on performance of daily activities and antacid use in patients with nonerosive symptomatic gastro-oesophageal reflux disease (gord) and frequent heartburn

• In: Posters: Community Pharmacy: Better outcomes for tomorrow
• At: Bangkok (Thailand) (2014)
• Type: Poster
• Poster code: POS-CPS140
• By: KATZ, Philip (Einstein Medical Center, Division of Gastroenterology, Philadelphia, United States of America)
• Co-author(s): Le Moigne, Anne (Pfizer Consumer Healthcare, Madison, United States of America)
  Park, Kelly (Pfizer Consumer Healthcare, Madison, United States of America)
  Pollack, Charles (Pfizer Consumer Healthcare, Madison, United States of America)
  
• Abstract:

  Background: Symptomatic GORD can impair performance of daily activities, and self-treatment of reflux symptoms (e.g., heartburn [HB] and acid regurgitation) with antacids is common. We evaluated patient-reported outcomes and antacid use in 2 studies of short-term esomeprazole (ESO) in patients likely to seek self-treatment in a pharmacy setting.
  Se..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login